OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 22, 2021
Patients reported more frequent and severe migraines, along with overuse of analgesics.
January 21, 2021
A study observed gaps in migraine knowledge in women’s health care providers. Pharmacists can play a role in provider education on prophylaxis and treatment.
January 15, 2021
Investigators observed that about half of patients treated with rimegepant showed a 50% or greater reduction in how many moderate-to-severe migraine days they experienced per month.
January 14, 2021
Pharmacists can provide education on migraine prophylaxis for better outcomes.
January 06, 2021
Researchers examined the 3 debated strategies for treating medication overuse headache.
January 05, 2021
A poster presented at the ASHP 2020 Midyear Clinical Meeting and Exhibition indicated opportunities for community pharmacists to improve outcomes for patients with migraines.
November 27, 2020
The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.
November 11, 2020
Add value by optimizing medications, decreasing pill burden.
May 27, 2020
Results from a phase 3 study showed that galcanezumab-gnlm (Emgality, Eli Lilly) significantly improved work productivity and health and well-being between migraine attacks.
May 25, 2020
Migraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.